Becton, Dickinson and Price Target Increased to $123.00 by Analysts at Deutsche Bank (BDX)
Equities researchers at Deutsche Bank raised their price target on shares of Becton, Dickinson and (NYSE:BDX) from $119.00 to $123.00 in a research report issued on Friday. Deutsche Bank’s price target indicates a potential upside of 5.96% from the company’s current price.
BDX has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Becton, Dickinson and in a research note on Friday. They now have a $122.00 price target on the stock. Separately, analysts at Barclays raised their price target on shares of Becton, Dickinson and from $115.00 to $121.00 in a research note on Friday. They now have an “underweight” rating on the stock. Finally, analysts at Morgan Stanley reiterated a “hold” rating on shares of Becton, Dickinson and in a research note on Friday. They now have a $123.00 price target on the stock, up previously from $119.00. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $113.23.
Becton, Dickinson and (NYSE:BDX) traded down 0.14% on Friday, hitting $116.08. The stock had a trading volume of 762,285 shares. Becton, Dickinson and has a 52-week low of $96.73 and a 52-week high of $120.66. The stock has a 50-day moving average of $118.6 and a 200-day moving average of $115.4. The company has a market cap of $22.427 billion and a P/E ratio of 24.25.
Becton, Dickinson and (NYSE:BDX) last released its earnings data on Thursday, July 31st. The company reported $1.65 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.67 by $0.02. The company had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the prior year, the company posted $1.58 earnings per share. The company’s quarterly revenue was up 5.1% on a year-over-year basis. Analysts expect that Becton, Dickinson and will post $6.25 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 30th. Stockholders of record on Tuesday, September 9th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 1.88%. The ex-dividend date is Friday, September 5th.
Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.